- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Pancreatic exocrine insufficiency
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 858KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 48KB)
Pancreatic extract – November 2020
Pancreatic extract: Capsule (containing enteric coated minimicrospheres) providing not less than 20,000 bp units of lipase activity, Capsule (containing enteric coated minimicrospheres) providing not less than 35,000 bp units of lipase activity; Creon®
Last updated
5 March 2021
